Activated PSA in the bone microenvironment was found to enhance tumor growth via the elevation of Wnt signaling and the upregulation of RNKL, TGF-β and RUNX-2, which promote osteoblastic differentiation and activity. This evidence concerns the gene TGFB1 and neoplasm.